Selector Raises $32M for AI Observability
Selector, a company providing an AI-powered observability platform to prevent downtime in digital infrastructure, has raised $32 million in funding. While not specific to consumer health, the investment signals strong investor appetite for AI-driven platforms that ensure reliability and uptime. This trend is mirrored in health tech, where system stability is critical for user trust and clinical adoption.
- The $32 million funding round doubled Selector's valuation to $375 million and was led by AVP, with participation from Ansa Capital, Two Bear Capital, and others. The funds are designated for accelerating AI innovation, product development, and global market expansion. This follows a year where Selector's annual recurring revenue grew to 230% of the previous year's levels, with new revenue booked reaching 370% of 2024's. - Consumer health apps like Headspace and Noom fuel user acquisition through a mix of content marketing, strategic partnerships, and freemium models. Noom utilizes a detailed, psychology-based onboarding quiz to create a personalized user journey, which builds trust and gathers data for personalization. - For a consumer health app, HIPAA compliance is triggered when personally identifiable information is combined with health data; however, state-level privacy laws in at least 20 states, such as California's CCPA/CPRA and Washington's My Health My Data Act, often have broader definitions of protected information that can include IP addresses or browsing data. - Integrating with wearables like Apple HealthKit, Fitbit, and Oura often requires navigating different API protocols, authentication flows, and data structures for each device, a process that can be streamlined using third-party APIs. While some platforms offer open developer portals, others like Garmin may require a more formal application and approval process. - Digital health saw a significant funding increase in 2025, reaching $14.2 billion, with AI-enabled companies securing 54% of that total and commanding a 19% premium on average deal size. Venture capital firms are increasingly backing startups that use AI for applications like personalized medicine and clinical decision support. - Patient advocacy blogs like "Chronic Eileen" and online communities such as The Mighty provide direct insight into the daily challenges of managing chronic conditions, revealing frustrations with the healthcare system and a desire for tools that aid in symptom tracking and communication with providers. - The longevity and biohacking space is attracting significant investment from tech entrepreneurs like Jeff Bezos (Altos Labs) and Sam Altman (Retro Biosciences), who are funding research into cellular reprogramming and senolytics. Startups in this area are also developing at-home testing and AI-driven apps to provide personalized health and longevity recommendations. - For founders transitioning from a developer role, early-stage digital health fundraising requires a compelling narrative that clearly defines the problem, the uniqueness of the solution, and its scalability. Accelerators focused on digital health, such as those run by Tenity, can provide access to investors, proof-of-concept opportunities with healthcare partners, and mentorship.
